As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

The Intraocular Lens Market is highly competitive, with major players focusing on innovation, acquisitions, and strategic alliances. Leading companies are investing heavily in R&D to develop lenses with enhanced visual outcomes and fewer post-surgery complications. Market entry barriers remain moderate, encouraging new players to introduce cost-effective lens solutions, especially in...

The Intraocular Lens Market is primarily driven by the rising incidence of cataracts and increased access to advanced eye care services. Modern intraocular lenses offer patients improved vision at multiple distances, reducing dependence on spectacles. Healthcare professionals are recommending lens replacement procedures earlier, resulting in a larger patient base and higher adoption rates. The...